Thromboelastographic® monitoring of the efficacy of recombinant factor VIIa administration in a parturient with factor VII deficiency [3]

Canadian Journal of Anesthesia

Volumn 53, Issue 5, 2006, Pages 528-529

  O'Rourke, Nollag ^a   Lee, Christopher ^a   Kodali, Bhavani Shankar ^a   Harnett, Miriam ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; CESAREAN SECTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABOR; LETTER; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; SPINAL ANESTHESIA; THROMBOELASTOGRAPHY; ARTICLE; PLASMA; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; BLOOD LOSS, SURGICAL; CESAREAN SECTION; FACTOR VII; FACTOR VII DEFICIENCY; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; INTERNATIONAL NORMALIZED RATIO; PARTIAL THROMBOPLASTIN TIME; PLASMA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTHROMBIN TIME; RECOMBINANT PROTEINS; THROMBELASTOGRAPHY;

EID: 33745781307     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03022632     Document Type: Letter

References (1)

1. Spahn DR, Tucci MA, Makris M. Is recombinant FVIIa the magic bullet in the treatment of major bleeding? (Editorial). Br J Anaesth 2005; 94: 553-5.